Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Wiener Medizinische Wochenschrift (1946)|October 19, 2002
[Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit]G D Birkmayer, G G Kay, E VürreCancer Detection and Prevention|January 1, 1981
Tumor markers of the central nervous systemG D BirkmayerCancer Detection and Prevention|January 1, 1983
Tumor markers of the central nervous system: biological basis and clinical relevanceG D BirkmayerJournal of Neural Transmission. Supplementum|January 1, 1986
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experienceW Birkmayer, G D BirkmayerInternational Journal of Cancer|April 15, 1980
Humoral immune response in glioma patients: A solubilized glioma-associated membrane antigen as a tool for detecting circulating antibodiesG D Birkmayer, H P StassDrugs Under Experimental and Clinical Research|March 15, 2003
Safety of stabilized, orally absorbable, reduced nicotinamide adenine dinucleotide (NADH): a 26-week oral tablet administration of ENADA/NADH for chronic toxicity study in ratsJ G D Birkmayer, K NadlingerJournal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|August 18, 2004
On the safety of reduced nicotinamide adenine dinucleotide (NADH)Jörg G D Birkmayer, Karl F R Nadlinger, Seth HallströmActa Neuropathologica|March 15, 1976
SV 40 related papova-viruses in human meningiomasA F Weiss, K D Zang, G D Birkmayer, et al.Biochimica Et Biophysica Acta|October 26, 2002
Extracellular metabolisation of NADH by blood cells correlates with intracellular ATP levelsKarl Nadlinger, Wilhelm Westerthaler, Danijela Storga-Tomic, et al.Pageof 3